De-Risking Discovery and Improving the Success Rates of Drug Development with AI
Update: 2025-12-11
Description
Gabi Tarcic, vice president of product for Evogene, sits down with Srivatsan Nagaraja about applying AI to small molecule drug discovery, the cultural and operational changes required for researchers to adopt these tools, and how AI-driven platforms can improve the efficiency of pharma R&D.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
